Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Ascentage Granted US Orphan Drug Status for Gastric Cancer Treatment

Week in Review: Baidu Raising $2 Billion for New China Biopharma

Week in Review: I-Mab Partners CD47 with AbbVie in $2 Billion Deal

BeiGene Acquires Global Rights (ex-China) to Singlomics' COVID-19 Antibodies

Sinovac Strikes Deal with Bio Farma to Produce CoronaVac for Indonesia

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020